<p><strong>Hepatotoxicity</strong>: Monitor liver function before and during therapy.<br />
<br />
<strong>Thrombotic or Thromboembolic Complications</strong>: Portal vein thrombosis has been reported in patients with chronic liver disease receiving Eltrombopag. Monitor platelet counts regularly.</p>